NEW YORK, Nov. 6, 2023 /PRNewswire/ — DanAds proudly announces the launch of Nine Ad Manager, a self-serve advertising platform that leverages Artificial Intelligence (AI) to empower Australian small and medium-sized businesses (SMBs) with the capability to purchase video advertising on 9Now, allowing precise targeting down to postcode levels and the creation of video creative through… Continue reading DanAds Empowers Nine with Revolutionary Self-Serve Ad Platform: Nine Ad Manager
Category: Newswire
DigiFabster and Materialise Collaborate to Integrate E-Commerce and Quoting Solution into Additive Manufacturing Workflow
DigiFabster, a quoting automation and e-commerce solution for advanced manufacturing companies, and Materialise, a global leader in 3D printing software and service solutions, announced a collaboration to connect DigiFabster’s automated quoting and eCommerce solution with Materialise CO-AM, an open software platform to manage the additive manufacturing (AM) production process. PASADENA, Calif., Nov. 6, 2023 /PRNewswire/… Continue reading DigiFabster and Materialise Collaborate to Integrate E-Commerce and Quoting Solution into Additive Manufacturing Workflow
AliveDx erhält IVDR-Zertifizierung für seine Produktionsstätten in der Schweiz und dem Vereinigten Königreich
EYSINS, Schweiz, 6. November 2023 /PRNewswire/ — AliveDx, ein weltweit tätiges In-vitro-Diagnostik-Unternehmen mit Hauptsitz in Eysins, Schweiz, gab heute bekannt, dass es nun die IVDR-Zertifizierung für seine beiden hochmodernen Produktionsstätten in Eysins, Schweiz, und Edinburgh, Vereinigtes Königreich, erhalten hat. AliveDx ist stolz darauf, bekannt zu geben, dass seine Produktionsstätten die Zertifizierung nach der In-Vitro-Diagnostik-Verordnung (IVDR) gemäß… Continue reading AliveDx erhält IVDR-Zertifizierung für seine Produktionsstätten in der Schweiz und dem Vereinigten Königreich
AliveDx recibe la certificación IVDR para sus sitios de fabricación en Suiza y Reino Unido
EYSINS, Suiza, 6 de noviembre de 2023 /PRNewswire/ — AliveDx, una empresa mundial de diagnóstico in vitro con sede en Eysins, Suiza, anunció hoy que ha recibido la certificación IVDR para sus instalaciones de fabricación de última generación ubicadas en Eysins (Suiza) y Edimburgo (Reino Unido). AliveDx se enorgullece de anunciar que sus instalaciones de… Continue reading AliveDx recibe la certificación IVDR para sus sitios de fabricación en Suiza y Reino Unido
NaughtOne Introduces Percy: A Bold, Versatile Lounge Chair
The latest addition to NaughtOne’s collection, Percy is a statement piece and a supremely comfortable sit HARROGATE, United Kingdom, Nov. 6, 2023 /PRNewswire/ — NaughtOne, a global furniture brand, today launches Percy, a striking yet simple lounge chair. From offices to universities to hospitality environments, Percy exemplifies adaptable design that is ideal for a wide… Continue reading NaughtOne Introduces Percy: A Bold, Versatile Lounge Chair
Markel strengthens its distribution team with digital & portfolio expertise
LONDON, Nov. 6, 2023 /PRNewswire/ — Markel, the insurance operation within Markel Group Inc. (NYSE: MKL), has appointed Chris Conyard as Digital & Portfolio Executive in its distribution strategies and business development (DS&BD) team. In his new position, Conyard will work closely with the underwriting and business development teams to support Markel’s long-term sustainable growth… Continue reading Markel strengthens its distribution team with digital & portfolio expertise
HPCL and Gogoro Announce Partnership To Rollout Battery Swapping Across Retail Outlets in India
Gogoro to rollout battery swapping stations to thousands of HPCL retail gas outlets across India in coming years. MUMBAI, India, Nov. 6, 2023 /PRNewswire/ — Gogoro Inc. (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, today announced it had signed a Memorandum of Understanding (MoU) with Hindustan… Continue reading HPCL and Gogoro Announce Partnership To Rollout Battery Swapping Across Retail Outlets in India
AliveDx reçoit la certification IVDR pour ses sites de production en Suisse et au Royaume-Uni
EYSINS, Suisse, 6 novembre 2023 /PRNewswire/ — AliveDx, une société mondiale de diagnostic in vitro dont le siège social se trouve à Eysins, en Suisse, a annoncé aujourd’hui qu’elle avait reçu la certification IVDR pour ses deux installations de fabrication de pointe situées à Eysins, en Suisse, et à Édimbourg, au Royaume-Uni. AliveDx est fière d’annoncer… Continue reading AliveDx reçoit la certification IVDR pour ses sites de production en Suisse et au Royaume-Uni
Cellenkos® Announces Oral Presentation and Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition
Oral presentation highlights the resolving of inflammation and superior homing to bone marrow of CXCR4-enriched T regulatory cells. Poster presentation includes safety and efficacy data from phase 1b LIMBER-TREG108 study evaluating CK0804, CXCR4 enriched, T regulatory cells, as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib. HOUSTON,… Continue reading Cellenkos® Announces Oral Presentation and Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition
Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission
Primary endpoint and all key secondary endpoints met with high statistical significance in GLOW study. With 6-month dosing of all patients, tarcocimab and the ABC platform continue to demonstrate differentiated durability. Following dialogue with US regulatory authorities, Kodiak plans to conduct one additional pivotal study with a commercial formulation of tarcocimab. New regulatory strategy could… Continue reading Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission